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Abstract 
It is well established that the metabolic risk factors of obesity and its comorbidities are more 
attributed to adipose tissue distribution rather than total adipose mass. Since emerging evi-
dence suggests that epigenetic regulation plays an important role in the aetiology of obesity, 
we conducted a genome-wide methylation analysis on eight different adipose depots of three 
pig  breeds  living  within  comparable  environments  but  displaying  distinct  fat  level  using 
methylated DNA immunoprecipitation sequencing. We aimed to investigate the systematic 
association between anatomical location-specific DNA methylation status of different adipose 
depots and obesity-related phenotypes. We show here that compared to subcutaneous ad-
ipose tissues which primarily modulate metabolic indicators, visceral adipose tissues and in-
termuscular adipose tissue, which are the metabolic risk factors of obesity, are primarily 
associated with impaired inflammatory and immune responses. This study presents epigenetic 
evidence for functionally relevant methylation differences between different adipose depots. 
Key  words:  pig,  subcutaneous  adipose  tissue,  visceral  adipose  tissue,  DNA  methylation, 
MeDIP-seq 
Introduction 
Obesity is a strong risk factor for the develop-
ment of type II diabetes mellitus, cardiovascular dis-
eases,  and  associated  metabolic  syndrome  [1].  An 
emerging view is that adipose tissue distribution in 
various locations of the body affects the development 
and progression of metabolic diseases more than total 
fat mass [2]. Adipose tissues from different areas of 
the body display distinct structural and biochemical 
properties and have disparate roles in pathology. It is 
well  known  that  visceral  adipose  tissues  (VATs), 
which  are  localized  within  the  abdominal  and  tho-
racic cavities, have been shown to be correlated with 
an increased risk of insulin resistance and cardiovas-
cular diseases [3, 4], whereas increase of subcutaneous 
adipose tissues (SATs) are associated with favorable 
plasma lipid profiles [5-7]. 
Recently, there has been a greater appreciation 
for the roles of DNA methylation markers, which can 
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be  very  dynamic  and  alter  gene  expression  in  re-
sponse  to  environmental  and  developmental  cues 
without  changing  DNA  sequences,  in  the  develop-
ment of obesity [8, 9]. Feinberg et al. (2010) identified 
four  variably  methylated  regions  correlated  with 
body mass index and were located in or near genes 
previously  implicated  in  the  regulation  of  body 
weight or diabetes [10]. Wang et al. (2010) provided 
evidence that obesity is associated with genome-wide 
DNA  methylation  changes  in  peripheral  blood  leu-
kocytes [11]. 
Pig models are ideal for studying human obesity, 
as they have many similarities in structure and func-
tion to humans, including size, digestive physiology, 
adipose distribution,  and  dietary habits [12, 13]. Of 
equal importance, the epigenetic understanding of pig 
adipose deposition will improve economic benefits in 
the pig industry. 
To  investigate  the  systematic  association  be-
tween DNA methylation and adipose deposition, we 
used a clustering method to identify sets of function-
ally  co-methylated  genes  linked  to  obesity-related 
phenotypes  based  on  the  comprehensive  ge-
nome-wide methylation data from eight adipose tis-
sues from different body sites used in Li et al. [14]. 
Materials and Methods 
Animals and tissue collection 
Three females and three males at 210-day-old for 
each of the Landrace (a leaner, Western breed), the 
Tibetan (a feral, Chinese breed) and the Rongchang (a 
fatty,  Chinese  breed)  pig  breeds  were  used  in  this 
study. These pigs lived in comparable environments, 
but  displayed  distinct  fat  levels.  The  eight  adipose 
tissues deposited in different body sites of each pig 
were sampled and divided into four groups: (1) three 
SATs  (i.e.  abdominal  subcutaneous  adipose  (ASA), 
inner layer of backfat (ILB), and upper layer of backfat 
(ULB)); (2) three VATs from the abdominal cavity (i.e. 
greater omentum (GOM), mesenteric adipose (MAD), 
and retroperitoneal adipose (RAD)); (3) one VAT from 
the  thoracic  cavity  (i.e.  pericardial  adipose  (PAD)); 
and  (4)  intermuscular  adipose  (IAD).  For  detailed 
information  regarding  the  animals  and  samples, 
please refer to Li et al. [14]. 
Measurements of obesity-related phenotype 
The representative obesity-related phenotypes of 
18 individuals were determined. The body density of 
each pig was calculated, as previously described [15]. 
The pig body is considered to be like a truncated cone 
where the base is represented by the abdomen (A), the 
top by the neck (N) and the length by the body size 
(BS). Pig body volume was defined (l) as: 
Volume (l) = (π (BS/3) (cm) × {(A)2 (cm) + (N)2 (cm) + 
(A (cm) × N (cm) ) } ) × 10-3 
where BS is the body size and A and N are the radius 
of the abdomen (A) and the neck (N). 
It was then possible to determine the density in 
kg per litter as: 
Density (kg·l-1) = BW (kg) / V(I) 
Serum  concentrations  of  total  cholesterol  (TC), 
triglycerides  (TG),  high  density  lipoprotein  (HDL), 
low density lipoprotein (LDL), very-low density lip-
oprotein  (VLDL),  lactate  dehydrogenase  (LDH), 
apolipoprotein  A-1  (Apo-A1)  and  apolipoprotein  B 
(Apo-B) were determined in triplicates for each pig by 
using CL-8000 clinical chemical analyzer (Shimadzu, 
Tokyo, Japan). Serum levels of 16 cytokines, which are 
well known to be associated with adipose deposition, 
were  measured  in  triplicates  for  each  pig  using  a 
pig-specific  ELISA  kit  (RuiCong,  Shanghai,  China). 
These  analyzed  molecules  included  adiponectin 
(Adipo),  adiponectin  receptor  (AdipoR),  C-peptide, 
cholecystokinin  (CCK),  gastrin  receptor  (GsaR), 
growth  hormone  (GH),  highly  sensitive  C-reactive 
protein (hs-CRP), insulin, interleukin - 6 (IL-6), leptin 
(Lep), leptin receptor (LepR), orexin-B (OX-B), orexin 
receptor  (OXR),  plasminogen  activator  inhibitor-1 
(PAI-1), tumor necrosis factor-α (TNF-α) and somato-
statin (SS). 
 Adipocyte volume was measured in each of 144 
adipose  samples,  as  previously  described  [16].  All 
adipose tissues were embedded in paraffin, sliced at a 
thickness of 6 μm and stained with hematoxylin and 
eosin.  The  mean  diameter  of  an  adipocyte  cell  was 
calculated as the geometric average of the maximum 
and minimum diameter, and 100 cells were measured 
for each sample in randomly selected fields. The mean 
adipocyte volume (V) was obtained according to the 
following formula: 
V = π/ 6 ∑fi Di3/ ∑fi 
where Di is the mean diameter; fi denotes number of 
celles with that mean diameter Di. 
Fatty acid composition was determined in each 
of 144 adipose samples  using GC-14C gas chromato-
graph (Shimadzu), as previously described [17]. The 
fatty acid methyl esters were quantified and identified 
by comparison with standards previously run inde-
pendently or together with samples. For more infor-
mation, please refer to Li et al. [14]. 
Methylated DNA immunoprecipitation se-
quencing 
In total, 144 adipose samples were used for the Int. J. Biol. Sci. 2012, 8 
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construction  of  methylated  DNA  immunoprecipita-
tion  (MeDIP)  libraries,  as  we  previously  described 
[18], and sequenced separately using Illumina HiSeq 
2000 sequencing system, which generated ～1,125 Gb 
of sequence data. All MeDIP-seq data were deposited 
into the NCBI’s Gene Expression Omnibus database 
under  the  GEO  Series  accession  number  GSE30344. 
We  referred  to  the  UCSC  pig  reference  genome 
(Sscrofa9.2) annotation data for the identification of 
differentially  methylated  regions  (DMRs)  in  17,930 
promoters  (-2,200  to  +500  bp)  across  eight  variant 
adipose tissues using our newly developed method-
ology by calculating the variation of a single CpG site. 
For more details, please refer to Li et al. [14]. 
Identification of co-methylated gene sets 
linked with obesity-related phenotypes 
In order to identify sets of functionally related 
genes with DMRs in their promoters that are linked to 
the phenotypic traits, we used a clustering method, as 
previously  described  [19],  albeit  with 
some  modifications.  Spearman  rank 
correlation  coefficients  were  deter-
mined  between  all  possible  gene-pairs 
across  18  individuals  for  each  type  of 
adipose tissue. The strongest correlated 
gene-pair  was  selected,  and  grouped 
together in a set that was assigned the 
average  methylation  value  of  the  two 
genes that constituted the set. After the 
addition of this newly created set to the 
dataset, the two individual genes were 
removed from the data and the strong-
est correlation in the dataset was again 
selected. This resulted in either the ex-
pansion of a set already created or in the 
creation of a new set. We kept repeating 
this  as  an  iterative  process  until  the 
most  significantly  correlated  pair  had 
an r < 0.80. Only the sets containing 100 
or  more  genes  were  kept  for  further 
analysis.  The  co-methylated  gene  sets 
that  reflected  the  average  methylation  value  of  the 
genes constituting that set were correlated with each 
of 29 obesity phenotypic traits using a non-parametric 
Spearman rank correlation coefficient with Bonferroni 
correction. 
Results and Discussion 
Co-methylated gene sets linked with obesi-
ty-related phenotypes 
As shown in Fig. 1, in a total of eight adipose 
tissues,  we  identified  44  co-methylated  gene  sets 
containing  100  or  more  genes  with  DMRs  in  their 
promoters.  These  gene  sets  comprised  different 
number of genes across different adipose tissues. For 
example, in ILB, 3,268 genes could be grouped into 
eight gene sets, whereas in GOM, 2,511 genes could be 
only  grouped  into  three  gene  sets.  Co-methylated 
genes within a single gene set are strongly correlated 
whereas genes that belong to different gene sets gen-
erally do not show strong co-methylation. 
 
 
 
Figure 1. Heat map of co-methylated gene sets in eight adipose tissues. Three SATs (abdominal subcutaneous adipose (ASA), 
inner layer of backfat (ILB), upper layer of backfat (ULB)); four VATs (greater omentum (GOM), mesenteric adipose (MAD), retroper-
itoneal adipose (RAD), pericardial adipose (PAD)); and intermuscular adipose (IAD). Pair-wise correlations between genes residing in all 
the gene sets were plotted. Gene pairs strongly positively or negatively correlated are shown in red or green, respectively. Colour 
intensity represents the strength of the correlation. The co-methylated gene sets are indicated by squares and are ordered by the number 
of genes; thus with the largest gene set - containing the largest number of genes - in the upper left corner and the smallest gene set in the 
lower right corner. 
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The gene sets of each adipose tissue were ana-
lyzed  for  correlation  with  various  obesity-related 
phenotypic traits of 18 pigs. Seven, eight, and three 
gene sets of SATs, VATs and IAD were significantly 
associated with a trait after Bonferroni correction for 
multiple testing (P < 0.001), respectively (Fig. 2). To 
further  define  the  biological  mechanisms  associated 
with  the  co-methylated  genes  that  are  correlated  to 
the phenotypic traits of obesity, we also performed a 
functional enrichment analysis of genes with DMRs in 
promoters using DAVID software [20] (Table 1). 
 
 
 
Figure 2. Correlations between co-methylated gene sets in eight adipose tissues and phenotypic traits of obesity. Log10 
P-values for Spearman rank correlation coefficients between the methylation values of the gene sets and the different phenotypic traits of 
obesity are shown. The gray shadow represents the Bonferroni corrected P-values that are greater than 0.001. SFA, MUFA, and PUFA, 
denote saturated, monounsaturated, and polyunsaturated fatty acids, respectively. 
 
 
Table 1. Top ten Gene Ontology (GO) and KEGG pathway categories enriched for co-methylated gene sets that corre-
lated with phenotypic traits of obesity. 
Correlated trait  Tissue (gene sets 
order No.) 
Functional 
category 
Term description  P value  Involved 
gene No. 
Apo-A1 
(Metabolic indicator) 
ASA (2) 
ILB (3) 
GO-BP  Cellular carbohydrate biosynthetic process  0.002  12 
GO-BP  Regulation of small GTPase mediated signal transduction  0.003  27 
GO-BP  Positive regulation of growth  0.006  11 
GO-BP  Carbohydrate biosynthetic process  0.008  14 
GO-MF  GTPase regulator activity  0.009  35 
GO-MF  Small GTPase regulator activity  0.009  27 
GO-BP  Glycerolipid metabolic process  0.021  20 
GO-BP  Positive regulation of cell proliferation  0.025  34 
GO-BP  Cholesterol metabolic process  0.029  13 
GO-BP  Response to steroid hormone stimulus  0.040  18 
HDL 
(Metabolic indicator) 
ILB (5) 
ULB (1) 
GO-MF  SH2 domain binding  0.003  17 
GO-MF  Manganese ion binding  0.008  25 
GO-BP  Gastrulation  0.009  20 
GO-BP  Regulation of response to external stimulus  0.009  26 
GO-MF  Enzyme activator activity  0.013  34 
GO-BP  Regulation of growth  0.015  34 Int. J. Biol. Sci. 2012, 8 
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GO-BP  Regulation of smoothened signaling pathway  0.016  16 
GO-BP  Positive regulation of anti-apoptosis  0.018  17 
GO-BP  Striated muscle tissue development  0.032  22 
GO-BP  Cell projection assembly  0.032  20 
LDL 
(Metabolic indicator) 
ASA (1) 
ULB (2,4) 
GO-BP  Cellular carbohydrate biosynthetic process  0.001  12 
GO-BP  Purine ribonucleoside triphosphate biosynthetic process  0.002  15 
GO-BP  Cellular polysaccharide biosynthetic process  0.002  8 
GO-BP  Positive regulation of biosynthetic process  0.003  72 
GO-BP  ATP biosynthetic process  0.003  14 
GO-BP  Ribonucleoside triphosphate biosynthetic process  0.003  15 
GO-BP  Positive regulation of macromolecule biosynthetic process  0.005  67 
GO-BP  Polysaccharide biosynthetic process  0.005  10 
GO-MF  Transferase activity, transferring nitrogenous groups  0.005  8 
GO-BP  Lipopolysaccharide metabolic process  0.007  4 
IL-6 
(Inflammatory and 
immune adipokine) 
GOM (1,3) 
PAD (3) 
IAD (4) 
GO-BP  Regulation of cell morphogenesis involved in differentia-
tion 
0.001  18 
GO-BP  Response to hypoxia  0.005  25 
GO-BP  Gliogenesis  0.011  16 
GO-BP  Immune response-activating cell surface receptor signaling  0.013  13 
GO-MF  Steroid hormone receptor binding  0.013  13 
GO-BP  Regulation of cell morphogenesis  0.023  22 
GO-BP  Positive regulation of leukocyte chemotaxis  0.023  9 
GO-BP  Immune response-regulating cell surface receptor signal-
ing 
0.023  13 
GO-BP  Regulation of cAMP metabolic process  0.031  19 
GO-BP  Regulation of leukocyte chemotaxis  0.033  9 
TNF-α 
(Inflammatory and 
immune adipokine) 
MAD (1) 
PAD (3) 
IAD (4) 
GO-BP  Leukocyte differentiation  0.003  16 
GO-BP  B cell activation  0.004  13 
GO-BP  Cellular component morphogenesis  0.005  28 
GO-BP  Lymphocyte differentiation  0.008  15 
GO-BP  B cell differentiation  0.012  11 
GO-MF  Small GTPase regulator activity  0.014  22 
GO-BP  Hemopoietic or lymphoid organ development  0.020  21 
KEGG   Primary immunodeficiency pathway  0.020  10 
GO-BP  Regulation of T cell activation  0.034  14 
GO-BP  Immune system development  0.036  21 
PAI-1 
(Inflammatory and 
immune adipokine) 
MAD (1,3) 
PAD (3) 
IAD (4) 
GO-BP  Leukocyte differentiation  0.004  18 
GO-MF  Magnesium ion binding  0.005  38 
GO-BP  Lymphocyte differentiation  0.006  17 
KEGG  Primary immunodeficiency pathway  0.007  11 
GO-BP  Hemopoiesis  0.009  25 
GO-BP  B cell activation  0.009  14 
GO-BP  Hemopoietic or lymphoid organ development  0.013  25 
GO-BP  T cell differentiation  0.015  13 
GO-BP  T cell differentiation in the thymus  0.020  10 
GO-BP  Immune system development  0.029  25 
In all tests, the unified set of co-methylated genes for different adipose depots that correlated to a phenotypic trait of obesity were compared 
with all known genes, which served as the background. P values (i.e. corrected EASE score), which indicated the significance of the overlap 
between various gene sets, was calculated using Benjamini-corrected modified Fisher’s exact test. BP, biological process; MF, molecular 
function. 
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SATs are associated with metabolic processes 
As shown in Fig. 2, the co-methylated genes in 
SATs modulate three metabolic indicators in serum, 
specifically Apo-A1, HDL and LDL. These indicators 
are primarily involved in metabolic processes, such as 
cellular carbohydrate biosynthesis, cholesterol, glyc-
erolipid,  and  lipopolysaccharide  metabolism,  and 
biosynthesis  of  cellular  carbohydrates,  polysaccha-
rides, and macromolecules (Table 1). 
This finding corroborated the notion that SATs, 
which are distributed over the body’s surface in the 
hypodermal  layer  of  the  skin,  mainly  contribute  to 
metabolism, and have direct and beneficial effects on 
the  maintenance  of  body  weight  and  metabolism 
[5-7].  It  is  noteworthy  that,  in  most  regions  of  the 
human and pig bodies, SAT is anatomically separated 
by  a  stromal  fascia  into  superficial  and  deep  SATs 
[21]. Walker et al. (2007) reported that compared to 
human  superficial  SAT,  deep  SAT  appears  to  be  a 
distinct adipose depot that supports an independent 
metabolic  function  and  may  be  associated  with  the 
risk  of  obesity-associated  complications  [22].  None-
theless, similar to the upper layer of porcine backfat 
(i.e. ULB), the co-methylated genes in the inner layer 
of porcine backfat (i.e. ILB) were related to two met-
abolic  indicators  (i.e.  Apo-A1  and  HDL),  and  were 
also mainly enriched in metabolic-related Gene On-
tology (GO) terms (Fig. 2). Currently, little is known 
about the species-specific differences in the distribu-
tion  of  adipose  tissues,  and  future  comprehensive 
comparisons of physiological and biochemical char-
acteristics between humans and pig will be beneficial 
in ascertaining this discrepancy in the results. 
VATs are attributed to inflammatory and 
immune processes 
As  shown  in  the  Fig.  2,  apart  from  RAD, 
co-methylated  genes  in  the  other  three  VATs  (i.e. 
GOM, PAD and MAD) were found to primarily affect 
three inflammatory and immune adipokines in serum: 
IL-6, PAI-1 and TNF-α. These adipokines are mark-
edly involved in the differentiation of B-cells, T-cells, 
leukocytes, and lymphocytes, and in the development 
of  the  immune  system,  and  hemopoietic  and  lym-
phoid organs. Consequently, these adipokines further 
attribute to the obesity-induced chronic inflammation 
in  adipose  tissue  that  precedes  the  development  of 
insulin resistance and type II diabetes mellitus [23-25]. 
It is believed that the distribution of adipose is 
an  important  predictor  of  metabolic  abnormalities, 
rather than total adipose mass [3, 4]. VATs are located 
within  the  abdominal  cavity  (i.e.  GOM  and  MAD), 
and have been recognized to be anatomically, func-
tionally, and metabolically distinct from SATs [3, 26]. 
Differences between VATs and SATs arise from the 
different genetic differentiation of pre-adipocytes and 
the influence of the local microenvironment [26]. The 
venous drainage of abdominal VATs is via the portal 
system,  which  directly  provides  free  fatty  acids 
(FFAs) as substrates for hepatic lipoprotein metabo-
lism  and  glucose  production  [27].  Compared  with 
SATs, VATs are more cellular, vascular, innervated, 
and  contain  a  larger  number  of  inflammatory  and 
immune  cells  [25].  VAT  adipocytes  are  more  meta-
bolically active and have a greater capacity to gener-
ate FFAs and uptake glucose than SATs, while SATs 
are more avid in absorbing circulating FFAs and tri-
glycerides  [2].  A  recent  study  on  the  autologous 
transplantation  of  VATs  to  subcutaneous  sites  sug-
gested that the DNA methylation status of the pro-
moters  of  adipokine  genes  across  different  adipose 
depots are anatomic location-specific, and are influ-
enced by the impact of local (residence) factors  [5]. 
With the exception of GOM and MAD, we did not 
identify gene sets of RAD that are significantly asso-
ciated with a phenotypic trait of obesity. This may be 
attributed  to  its  special  anatomical  location,  which 
surrounds the  kidneys at the dorsal side  of the ab-
dominal cavity. Blood from omental GOM and mes-
enteric MAD drains into the portal vein, while blood 
from retroperitoneal RAD does not. 
Interestingly,  we  also  found  that  the 
co-methylated genes of PAD, which is located within 
the thoracic cavity and surrounds the heart, primarily 
affect inflammatory and immune adipokines (i.e. IL-6, 
PAI-1 and TNF-α) (Fig. 2). This observation confirms 
the evidence that PAD is a correlative risk factor for 
cardiovascular disease [28], especially coronary heart 
disease owing to the marked feature of inflammation 
[29].  Additionally,  similar  to  high-risk  VATs,  the 
co-methylated genes of intermuscular IAD, which is 
believed to provide fuel for skeletal muscle contrac-
tion, were found to affect IL-6, PAI-1 and TNF-α (Fig. 
2), suggesting that it is an independent risk factor for 
metabolic diseases [30].  
Conclusion 
The present study found that intrinsic methyla-
tion differences between various adipose depots are 
dependent  on  their  localization.  Additionally,  we 
presented  epigenetic  evidence  that  both  VATs  and 
IAD, which are metabolic risk factors of obesity, are 
also associated with an impaired immune response. 
Our observations suggest a potential strategy for the 
development of future epigenetic biomarkers for the 
prediction and prevention of obesity.  Int. J. Biol. Sci. 2012, 8 
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